Acts as a temporary replacement of the synovial fluid and supports pain relief and restoration of joint function after arthroscopy in the knee or shoulder joint.
0.5% hyaluronic acid obtained by biofermentation
Free from animal protein
Structure matches the natural hyaluronic acid present in human body (no chemical modification)
Terminal sterilisation by autoclave (SAL6)
Efficacy demonstrated in clinical studies: quicker recovery of mobility1 and reduced pain2 after the arthroscopy
Registered under Act 737
MDA Reg. No. GD14886330617
The contents and the outer surface of the VISCOSEAL® SYRINGE pre-filled syringe are sterile as long as the sterile pack remains intact. VISCOSEAL® SYRINGE should be used at the end of arthroscopy after completion of the normal irrigating procedure. Take the pre-fillled syringe out of the sterile pack. Remove the cap, attach a suitable needle and secure it by turning slightly. Remove any air bubble, if present, before injection. Introduce VISCOSEAL® SYRINGE into the joint cavity. Alternatively, the pre-filled syringe may be placed directly into a portal in the joint. The introduction of VISCOSEAL® SYRINGE into the joint cavity will help to wash out the remaining irrigation solution.
For doctor use only
Proven Efficacy
VISCOSEAL® SYRINGE temporarily replaces the synovial fluid in the joint.
Villamor A et al., Osteoarthritis Cartilage. 2004; 12 (Suppl B): S 82.
de Heus JAC, Vuylsteke KH, Declercq GA. OUP. 2016;5(10):582-91. German.
You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.
As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.
